Liying Biotech's AI-assisted protein structure design platform can assist in protein function expansion, significantly improve protein performance, increase production throughput, process yield, and expand the applicable directions of protein products. It shortens the research and development production cycle. We utilize next-generation AI algorithms, with AlphaFold as a representative, to analyze, simulate, and optimize the critical properties and structures of proteins. After initial screening and experimental verification by Liying Biotech's technical team based on the physical-chemical environment or biological functional pathways of amino acids, it accelerates the process of protein sequence evaluation. It can quickly determine the modification directions and efficient expression routes for different proteins, considering the requirements of different scales and process routes, to achieve the rapid acquisition of targeted proteins.

Liying Biotech's High Throughput Screening (HTS) platform is an advanced technology platform based on a profound understanding of molecular biology, structural biology, and protein biochemistry. This platform is a well-established high-throughput technology route, which optimizes workflow, improves experimental efficiency, enhances speed and throughput capabilities, shortens project timelines, and reduces project costs. The high-throughput screening platform propels traditional laboratories towards scalability, standardization, and automation, providing efficient support and validation for front-end sequence computation and design.

By combining the BDLT loop with traditional biology, we follow the concept of systematic design and engineering to construct and screen engineered strains that exhibit high quality, high yield, and stability. Currently, they have obtained base strains including Escherichia coli, Lactobacillus, Saccharomyces cerevisiae, and brewing yeast.

The Single B Cell Antibody Screening Platform is a platform that utilizes high-throughput cell sorting and single B cell PCR amplification techniques to screen for high-affinity and specific monoclonal antibodies. This platform has wide applications in antibody drug development, biomarker research, medical diagnostics, and other fields. Liying Biotech's use of this platform has significantly shortened the antibody screening cycle and accelerated the project's development process.

Liying Biotech's pairing, screening, and validation platform for protein CROs combines the requirements of the target protein in different application scenarios. This includes, but is not limited to, a variety of physical and functional tests such as molecular interaction experiments, functional biochemical assays, thermal stability testing, ELISA, lateral immunochromatography, cell scratch assays, and cell proliferation assays. These tests further validate the function of the target protein and ensure that it can meet customer requirements.